Deep Tech Startups

Aliena develops electric propulsion systems, including Hall thrusters and hollow cathodes, for commercial, government, and research satellites. The company designs integrated propulsion architectures to enable spacecraft to operate longer and travel further with improved mission flexibility.

2 investors

Aligned Bio develops nanowire-based biosensor platforms capable of detecting single molecules, serving customers in diagnostic and research applications. The company manufactures advanced sensors using proprietary methods for organizing and functionalizing nanowires on various substrates.

2 investors

Alithea Genomics develops RNA sequencing technologies and platforms that enable pharmaceutical, agritech, cosmetics, and academic teams to generate large-scale transcriptomic datasets for compound screening, crop engineering, and ingredient development. The company's plate-based, high-throughput solutions reduce costs, hands-on time, and environmental impact compared to standard RNA-seq practices.

2 investors

Alpha Tau Medical develops Alpha DaRT, a technology platform for cancer treatment using targeted alpha radiation therapy across multiple cancer types including skin, pancreatic, brain, lung, and prostate cancers at various clinical stages.

2 investors

Alpine Eagle is a European defence technology company that develops airborne counter-UAS (c-UAS) systems to protect critical assets and personnel from autonomous drone threats. Its systems serve military and security forces, working with European and allied partners.

2 investors

Alqem uses AI combined with domain expertise in chemistry and physics to discover new crystalline materials, aiming to identify breakthrough materials validated in the real world. The company operates in materials discovery for the chemical and energy industries.

2 investors

Also Capital is an early-stage venture capital firm that backs technically ambitious founders working on hard engineering and science problems, often at inception before markets are defined. It runs concentrated funds of roughly 15 core companies each, and has invested in over 30 companies since 2019 across deeptech, space, and other frontier sectors.

2 investors

Atlas AI provides wet-lab, bioinformatics, and AI services on a modular, expert-led basis, helping clients with experimental execution, data generation, analytical pipelines, and deployed software systems. It serves partners across biotech, healthtech, and industrial domains, from early-stage research through applied R&D and pre-industrial development.

2 investors

Alt Carbon is a deeptech science and data company building agricultural infrastructure for carbon dioxide removal in South Asia through Enhanced Rock Weathering and other technology pathways. The company works with farmers and scientists to convert underutilized land into carbon sinks while reviving degraded soils and restoring livelihoods.

2 investors

Altara builds AI agents purpose-built for the physical sciences, automating scientific and engineering workflows such as experimental design, yield analysis, anomaly detection, and failure analysis. It connects to a company's existing siloed data sources without migrations to accelerate work from R&D through manufacturing for startup and enterprise customers.

2 investors

Altasciences operates a drug development platform that integrates nonclinical research, bioanalysis, manufacturing, and Phase I/II clinical execution to compress early-stage drug development timelines from industry standards of 27–51 months to as little as 18 months. The company serves biotech sponsors developing small molecules, monoclonal antibodies, and emerging modalities through parallel workstreams across all development phases.

2 investors

Altavo develops non-invasive silent speech technology using RF sensing and artificial intelligence to help patients who have lost their voice regain natural-sounding speech. The company focuses initially on laryngectomy patients and operates as a medical device startup in Germany.

2 investors

Alva develops solutions for delivering new nuclear power generation capacity on time and on budget, serving utilities and energy operators building utility-scale nuclear systems.

2 investors

AM Craft manufactures customized plastic components for aircraft seating using 3D printing technology, serving aerospace suppliers and airlines seeking reduced lead times and part consolidation.

2 investors

Amaryllis Tx develops tissue-targeted drug delivery by mapping tissue-specific glycan signatures and designing peptides that recognize them, using in silico and in vivo screening. Its lead peptide enables subcutaneously injected payloads such as antibodies, mRNA, ASO, and siRNA to cross the blood-brain barrier, initially targeting the brain.

2 investors

AmberBox makes an indoor gunshot detection and response system that uses a patented tri-factor authentication method (percussion, audio, and infrared) to identify firearm discharges and automatically alert first responders. The system integrates with other security infrastructure such as cameras, access control, and mass notification systems, and is marketed for use in the United States.

2 investors

Amentum delivers engineering, design, and project management services for advanced energy solutions, including nuclear, fusion, and hydrogen technologies. The company serves energy clients worldwide seeking to transition away from fossil fuels and develop next-generation power systems.

2 investors

Amnova Biotech develops injectable therapies derived from amniotic biomaterials to promote heart regeneration following ischemic injury. The company targets cardiac regenerative medicine and is advancing its lead therapies from preclinical validation toward clinical application.

2 investors

Amphiform engineers advanced materials for next-generation energy sources using precision manufacturing techniques. The company develops clean, abundant energy technologies designed to power electrified industry, intelligent machines, and space exploration.

2 investors

Amsel Medical develops minimally invasive vessel occlusion devices for vascular surgery, trauma care, and interventional procedures. The company's products, including the SCureClamp iDOT and SCureTOTM, are designed to occlude blood vessels for applications ranging from venous disease treatment to combat hemorrhage control.

2 investors

AnaBios generates predictive human data for pharmaceutical drug development, using authentic human cells and tissues from healthy and diseased donors to assess drug efficacy and toxicity before clinical trials. It offers human tissue procurement and functional assay services, including gene expression, proteomic, and metabolomic profiling, to support drug discovery and preclinical safety testing.

2 investors

AnalogAI develops neuromorphic semiconductor chips based on analog in-memory computing (AIMC), using variable-resistance synapse components to perform the vector and matrix operations needed for AI. Its technology targets on-device AI applications such as real-time AI companions, autonomous vehicles operating offline, and offline language translation.

2 investors

Angular Ventures is an inception-stage venture capital firm that invests in technical founders building deep-tech and enterprise companies across Europe and Israel.

2 investors

Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases. It uses a technology platform to discover active pharmaceutical ingredients designed for veterinary patients.

2 investors